Bain Capital to acquire Vitabiotics in £900m deal

Bain Capital has finalized a deal to acquire Vitabiotics, a leading British vitamins and supplements company, for around £900 million. This acquisition underscores the growing trend of private equity firms investing heavily in health-related businesses, reflecting a broader consumer shift towards wellness and preventive health. Such moves are likely to reshape the competitive landscape in the supplements market and could signal Bain Capital's strategy to bolster its portfolio in the health sector. For Vitabiotics, this deal offers significant growth opportunities and resources to expand its global footprint.